MedPath

An Open-Label, Single-Center Study Evaluating the Effect of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in Patients Diagnosed With Dry Eye

Not Applicable
Completed
Conditions
Dry Eye Syndrome
Interventions
Other: SYSTANE® Balance Lubricant Eye Drops
Registration Number
NCT01223040
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to evaluate the effect of acute and repeat dosing of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in a population of dry eye patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients must have history of mild-moderate dry eye with use of (or desire to use) eye drops in past 6 months
Read More
Exclusion Criteria
  • Patients cannot wear contact lenses within 1 week prior nor during the study, and cannot have a history of hypersensitivity to any component of Systane Balance.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SYSTANE® Balance Lubricant Eye DropsSYSTANE® Balance Lubricant Eye DropsSYSTANE Balance Lubricant Eye Drops dosed (bilaterally) in the office during each visit. Between visits 2 and 3, patients will dose 4 times per day for the 7 day period.
Primary Outcome Measures
NameTimeMethod
Changes in video Ocular Protection Index 10 and 55 minutes following Systane Balance instillation at Days 1 and 7.8 days
Secondary Outcome Measures
NameTimeMethod
Changes in blink pattern in subjects with mean Interblink Interval (IBI) < 3 seconds at Days 2 and 89 days
Fluorescein staining at Visits 1 & 3 on the Ora staining scale9 days
Ocular Symptomology at each visit9 days
© Copyright 2025. All Rights Reserved by MedPath